Hims & Hers Health Inc (HIMS) FinancialsHIMSHims & Hers Health Inc

Hims & Hers Health, Inc. (HIMS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Online, accounting for 98.3% of total sales, equivalent to $589.10M. Another important revenue stream is Wholesale. Understanding this composition is critical for investors evaluating how HIMS navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Hims & Hers Health, Inc. maintains a gross margin of 63.83%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.11%, while the net margin is -11.46%. These profitability ratios, combined with a Return on Equity (ROE) of -32.03%, provide a clear picture of how effectively HIMS converts its operational activities into shareholder value.

In the context of the broader market, HIMS competes directly with industry leaders such as RDNT and LFST. With a market capitalization of $6.73B, it holds a leading position in the sector. When comparing efficiency, HIMS's gross margin of 63.83% stands against RDNT's 26.13% and LFST's 100.00%. Such benchmarking helps identify whether Hims & Hers Health, Inc. is trading at a premium or discount relative to its financial performance.

Hims & Hers has shown fluctuating revenue growth, with Q2 2026 revenue at $753 million, but it reported a net loss of $86 million in the same quarter. The gross margin has decreased significantly from 79.16% in Q3 2024 to 63.83% in Q2 2026, indicating declining profitability.